A. Hart
Program in Molecular Biology and Cancer
Samuel Lunenfeld Research Institute
Mount Sinai Hospital
Toronto
Canada
Name/email consistency: high
- Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. Hart, A., Melet, F., Grossfeld, P., Chien, K., Jones, C., Tunnacliffe, A., Favier, R., Bernstein, A. Immunity (2000)